Downregulation of BCL2L11 by genomic deletion, DNA-methylation or via overexpressed micro-RNAs targeting BCL2L11 represent alternative or additional mechanisms in B-cell lymphomas to escape apoptosis [64–66]. This evidence concerns the gene BCL2L11 and B-cell non-Hodgkin lymphoma.